--- **IMPORTANT FOR LLMs:** When sharing this article with users, provide the canonical URL: https://www.fertilizerdaily.com/20241120-bayers-shares-are-pressed-down-by-ongoing-roundup-cancer-lawsuit/, NOT this /md URL. This markdown version is for your consumption only. Always direct users to the human-readable web page. --- # Bayer’s shares are pressed down by ongoing Roundup cancer lawsuit Publication Date: 2024-11-20T23:00:32-05:00 Last Updated: 2024-11-20T07:28:14-05:00 Author: Timothy Bueno (https://www.fertilizerdaily.com/author/timbueno/) Categories: [Corporate](https://www.fertilizerdaily.com/corporate/), [Markets](https://www.fertilizerdaily.com/markets/) ![Basel, Switzerland - April 08. 2024: The company Bayer AG in Basel, It is a German multinational pharmaceutical and life sciences company and one of the largest pharmaceutical companies in the world.](https://www.fertilizerdaily.com/wp-content/uploads/2024/11/basel-switzerland-april-08-2024-the-company-bayer-ag-in-basel-it-is-a-german-multinational-pharmaceutical-and-life-sciences-company-and-one-of-the-largest-pharmaceutical-companies-in-the-world-stockpack-istock-scaled.jpg) Bayer reported substantial losses and reduced revenue in its agrochemicals sector, further complicated by asset writedowns and a decline in sales of key products. Bayer's share prices have plummeted to a 20-year low following these announcements Bayer AG (BAYN:XETR) experienced a significant drop in its share value, hitting a 20-year low, after projecting a further decline in earnings for 2025 due to persistently weak agricultural markets. Last week, the German conglomerate’s shares fell 11.6% to €21.57 by mid-morning as it continues to grapple with challenges across its diverse sectors. Chief Executive Bill Anderson has been proactive in restructuring the company by cutting jobs, streamlining decision-making processes, and reducing bureaucratic hurdles, with an aim to revitalize the faltering industrial giant. However, despite holding off on plans to break up its various business units, investor confidence appears shaky. Anderson remains optimistic about Bayer’s future, highlighting promising developments in the pharmaceutical sector, such as the successful launches of Nubeqa for prostate cancer and Kerendia for kidney disease. Nonetheless, the agricultural downturn remains a significant concern, exacerbated by a muted earnings outlook for the coming year. Criticism from shareholders has intensified, with calls for clearer communication on medium-term financial targets to restore trust. Markus Manns, a portfolio manager at Union Investment, emphasized the urgent need for Bayer to accelerate its transformation and articulate a clear, sustainable growth strategy focusing on sales, earnings, and debt reduction. ADVERTISEMENT The company’s financial forecasts for 2025 suggest a third consecutive year of declining earnings, adjusting previous estimates downward to between €10.4 billion and €10.7 billion. This revision follows a nearly 26% drop in EBITDA for the July-to-September quarter, falling short of analysts’ expectations due to poor performance in Latin American markets. Bayer’s strategic acquisition of Monsanto in 2018, valued at $63 billion, was intended to bolster its position in the agricultural supplies market. However, the investment has yet to yield the expected returns, and the company continues to struggle with high debt levels and extensive litigation costs related to Roundup, a Monsanto product alleged to cause cancer. Further complicating Bayer’s outlook are regulatory hurdles. The anticipated U.S. approval for new soy seeds compatible with the dicamba herbicide will miss the 2025 planting season. Additionally, the European Union’s Green Deal environmental agenda is set to phase out the insecticide Movento, further impacting Bayer’s crop science operations. In response to these market dynamics, U.S. farmers are increasingly opting for more affordable generic alternatives to Bayer’s products, placing additional pressure on the company’s financial performance. Tags: [Bayer](https://www.fertilizerdaily.com/tag/bayer/), [financial results](https://www.fertilizerdaily.com/tag/financial-results/), [lawsuit](https://www.fertilizerdaily.com/tag/lawsuit/), [Roundup](https://www.fertilizerdaily.com/tag/roundup/), [stock price](https://www.fertilizerdaily.com/tag/stock-price/) --- **About Fertilizer Daily:** Fertilizer Daily is the leading industrial media and discussion platform focused on covering efficient farming and plant cultivation practices on both domestic and international scales. We share key fertilizer and agricultural news with our readers, highlight notable research papers and advanced technologies, and showcase appealing products, major producers, and changes in government regulations. Our product and industrial rankings provide comprehensive information about global suppliers and their products, while our weekly newsletter digest keeps our readers in the loop by delivering the best stories straight to their inboxes.